Sequelae and survivorship in patients treated with (131)I-MIBG therapy

about

Iodine-131-meta-iodobenzylguanidine therapy for patients with newly diagnosed high-risk neuroblastoma.Local recurrence of pheochromocytoma in multiple endocrine neoplasia type 2A: a diagnostic and therapeutic challenge.Phaeochromocytoma and Paraganglioma.

P2860

Q36353230-64A3E030-6288-4E48-B291-3FAAB0C005F6 Q38685712-B70882FA-E776-4983-A543-1A782BAEA1AC Q39020433-CBA7D08F-F2F9-4E05-B66E-40963B9855D6

P2860

Sequelae and survivorship in patients treated with (131)I-MIBG therapy

Item

http://www.wikidata.org/entity/Q37081870

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Sequelae and survivorship in patients treated with (131)I-MIBG therapy

@en

Sequelae and survivorship in patients treated with

@nl

type

Item

label

Sequelae and survivorship in patients treated with (131)I-MIBG therapy

@en

Sequelae and survivorship in patients treated with

@nl

prefLabel

Sequelae and survivorship in patients treated with (131)I-MIBG therapy

@en

Sequelae and survivorship in patients treated with

@nl

P1476

Sequelae and survivorship in patients treated with (131)I-MIBG therapy

@en

P2093

A B Grossman

http://www.w3.org/2001/XMLSchema#string

D Amendra

http://www.w3.org/2001/XMLSchema#string

I Goddard

http://www.w3.org/2001/XMLSchema#string

M R Druce

http://www.w3.org/2001/XMLSchema#string

P N Plowman

http://www.w3.org/2001/XMLSchema#string

S A Akker

http://www.w3.org/2001/XMLSchema#string

S C C Shieh

http://www.w3.org/2001/XMLSchema#string

W C C Sze

http://www.w3.org/2001/XMLSchema#string

W M Drake

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.

Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms.

Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma

Low-dose iodine-131 metaiodobenzylguanidine therapy for patients with malignant pheochromocytoma and paraganglioma: single center experience.

Radionuclide therapy in neuroendocrine tumours: a systematic review.

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.

Neuroendocrine tumours.

Everolimus for advanced pancreatic neuroendocrine tumors.

Iodine -131 metaiodobenzylguanidine is an effective treatment for malignant pheochromocytoma and paraganglioma.

The role of chemotherapy in the nonsurgical management of malignant neuroendocrine tumours.

P2888

bjc.2013.365

P304

565-572

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2013.365

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

249966293

http://www.w3.org/2001/XMLSchema#string

P698

23860527

http://www.w3.org/2001/XMLSchema#string

P932

3738119

http://www.w3.org/2001/XMLSchema#string

Sequelae and survivorship in patients treated with (131)I-MIBG therapy

about

P2860

P2860

Sequelae and survivorship in patients treated with (131)I-MIBG therapy

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932